In this issue:
Coronary artery disease progression and biologicals for severe psoriasis
Subclinical CV disease improvements after anti-TNF-α agents for severe psoriasis
Tofacitinib and CV risk factors/ outcomes in plaque psoriasis
Lichenoid mucocutaneous eruptions due to anti-PD-1/PD-L1 agents
BF-200 ALA as field-directed treatment of mild-to-moderate AK with PDT
FFC: possible association with facial skin care products and sunscreens
Topical tofacitinib for atopic dermatitis
Topical therapies for pyoderma gangrenosum
Hair follicle-containing punch grafts accelerate chronic ulcer healing
Low-dose isotretinoin for presenile diffuse familial sebaceous hyperplasia
Please login below to download this issue (PDF)